General Office of China Council, General Office of the State Council Issue Proposal on “Further Improve the Drug Registration Process, Advocate Innovation in Drug Development.”
China propel the reformation in drug registration and development from top government level: proposal issued by General Office of China Council and General Office of the State Council. Once adopted, the China regulations will be closer to the FDA and EMA counterparts.
Source: http://www.gov.cn/xinwen/2017-10/08/content_5230105.htm